By Maggie Fick and Natalie Grover (Reuters) – GSK on Wednesday beat fourth-quarter profit and sales forecasts helped by sales of its blockbuster shingles vaccine Shingrix and unveiled an upbeat forecast for 2023. The positive outlook and strong Q4 results are the latest endorsement of chief executive Emma Walmsey’s spin-off last year of consumer business…
SHANGHAI (Reuters) – Chinese investors are starting to shift money from bonds to stocks, betting on a robust recovery for riskier assets as the government’s policy pivots to boost growth, the latest report on mutual funds showed. Foreign money has also been flowing into China equities, sending the benchmark index up 7.4% in January, although…
ZURICH (Reuters) – ABB has raised 325 million Swiss francs ($355 million) from selling a further part of its electric vehicle (EV) charging business to four minority investors, the Swiss engineering and technology company said on Wednesday. The investors will take a combined 12% stake in the E-Mobility business in the final round of private…
By Ludwig Burger BASEL (Reuters) -Swiss drugmaker Novartis on Wednesday predicted that core operating income would grow in a “mid single digit” percentage range in 2023, following stagnation last year. Full-year core operating income was broadly flat at $16.7 billion, it said in a statement, coming in slightly below market expectations of $16.8 billion. Adjusted…
BERLIN (Reuters) – The United States remained the most important destination for German exports in 2022 for the eighth consecutive year. Exports of goods reached a record 156 billion euros ($169.31 billion) last year, according to Reuters calculations based on preliminary data from the German statistics office. German exports to the United States in 2022…
